20269 ⎘
Medicinal preparations containing organic active ingredients Nitriles; Isonitriles
Methods for alleviating deleterious effects of 3-deoxyglucosone
#302Selective androgen receptor modulators and methods of use thereof
#303Methods for alleviating deleterious effects of 3-deoxyglucosone
#304Methods and compositions for treating migraine pain
#305Calcium receptor-active molecules
#306Methods and compositions for specific inhibition of protein splicing by small molecules
#307Use
#308Compositions and methods for treating tissue ischemia
#309BTK inhibitors
#310Chemical compounds
#311Bis(thio-hydrazide amides) for increasing Hsp70 expression
#312Novel signaling pathway for the production of inglammatory pain and neuropathy
#313Agents which regulate, inhibit, or modulate the activity and/or expression of lysyl oxidase (LOX) and LOX-like proteases as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
#314Medicament for treatment of diabetes
#315Inhibitors against the activation of ap-1 and nfat
#316Vesicant treatment with phenyl-phenyl type vitamin d receptor modulators
#317Nf-kb activation inhibitors
#318Compounds and therapies for the prevention of vascular and non-vascular pathologies
#319Pharmaceutical formulation comprising (r)-bicalitamide
#320Irreversible selective androgen receptor modulators and methods of use thereof
#321Methods of inducing ovulation
#322Therapeutic compounds and methods of use
#323Non-steroidal anti-androgen therapy
#324Inhibition of mitogen-activated protein kinase (MAPK) pathway: a selective therapeutic strategy against melanoma
#325Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
#326Substituted pyrazoles
#327Inhibition of biogenic sulfide production via biocide and metabolic inhibitor combination
#328Substituted pyrazoles
#329Venlafaxine compositions in the form of microtablets
#330Product comprising an inhibitor of the transduction of heterotrimeric G protein signals combined with an anti-hypertensive agent for therapeutic use in the treatment of arterial hypertension
#331Methods of indirectly stimulating the vagus nerve with an electrical field
#332Nitrate esters and their use for mitigating cellular damage
#333Methods for using amino acids with affinity for the α2δ-protein
#334Compositions and methods for inhibiting NF-κB mediated tumorigenicity and adhesion dependent survival of cancer cells
#335Method for the improvement of neuronal regeneration
#336Agents for the prevention or treatment of renal diseases
#337Cell line comprising vector encoding truncated FLK-1 receptor
#338Method for treating allergies using substituted pyrazoles
#339Composition and method to treat solid tumors
#340Pharmaceuticals for the treatment of rejection reactions in organ transplantations
#341Use of sugar phosphates, sugar phosphate analog, amino acids, amino acid analogs for modulating transaminases and/or the association of p36/ malate dehydrogenase
#342Compounds and therapies for the prevention of vascular and non-vascular pathologies
#343Polymer adhesives comprising a low boiling point biocompatible solvent, high molecular weight multi-arm star cyanoacrylate-telechelic polyisobutylene and 2-octyl cyanoacrylate